大動脈内移植片の世界市場

大動脈内移植片の世界市場は2030年までに36億米ドルに到達

2024年に29億米ドルと推定される大動脈内移植片の世界市場は、2024～2030年の分析期間においてCAGR 3.7%で成長し、2030年には36億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである腹部大動脈グラフトは、CAGR 3.1％を記録し、分析期間終了時には24億米ドルに達すると予測されます。胸部大動脈グラフトセグメントの成長率は、分析期間のCAGRで5.1％と推定されます。

米国市場は7億9,610万米ドルと推定、中国はCAGR6.8％で成長予測

米国の大動脈内移植片市場は、2024年に7億9,610万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.8%として、2030年までに7億2,850万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5%と2.8%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の大動脈内移植片市場- 主要動向と促進要因のまとめ

大動脈内移植片が動脈瘤修復と血管疾患管理の標準治療を再定義する理由とは？

血管内動脈瘤修復術（EVAR）と胸部血管内大動脈修復術（TEVAR）に使用される大動脈内移植片は、周術期リスク、入院期間、回復時間を大幅に短縮する低侵襲的介入を可能にすることで、大動脈瘤の治療に革命をもたらしました。これらの移植片とステントのハイブリッドは大動脈内に配置され、動脈瘤嚢を血流から排除し、血管の連続性を保ちながら破裂を防ぐ。EVARの使用は、腹部大動脈瘤（AAA）や胸部大動脈瘤（TAA）の管理において、特に開腹手術の理想的な候補者ではない高リスクの患者や高齢者において中心的なものとなっています。

開腹手術からEVARやTEVARへの移行は，手技による死亡率の低下，術後合併症の減少，患者の迅速な移動など，強力な臨床的アウトカムに支えられています。大動脈内移植片は、動脈瘤の破裂や外傷性大動脈損傷など、待機的な場面でも緊急の場面でもますます使用されるようになっており、急性血管治療におけるその重要性が高まっていることを物語っています。自己拡張型金属ステントと生体適合性グラフトファブリックから構成される精密工学的アーキテクチャにより、複雑な解剖学的形状や困難な血管アクセス経路に対するテーラーメイドのソリューションが可能になります。

動脈瘤の排除にとどまらず、大動脈内移植片は、大動脈解離、貫通性アテローム性動脈硬化性潰瘍、および胸部および腹部大動脈を含むその他の病態に対するハイブリッドおよび分岐血管内治療において支持を集めています。このような適応の拡大は、支持される臨床データおよび外科的専門知識の発展とともに、血管外科医およびインターベンショナル・ラジオロジストによる採用の拡大を促しています。患者選択の幅が広がり、機器の汎用性が向上するにつれ、大動脈内移植片は血管医療における治療の可能性を再定義しています。

機器設計の革新と画像診断の統合は、手技の精度と治療成績をどのように向上させているか？

デバイス設計の進歩により、大動脈内移植片は、大動脈の直径、屈曲度、分岐血管の近接度などの様々な変化に対応する、高度にカスタマイズ可能な解剖学的適合性を持つインプラントへと変化しています。モジュール式グラフトシステム、薄型デリバリーシース、および再配置可能なステントコンポーネントにより、狭い腸骨動脈や石灰化した腸骨動脈を通過するナビゲーションが改善され、過酷な解剖学的構造を持つ患者でも安全な展開が可能になっています。腎上固定、アクティブシールリング、柵状または分岐型デザインの統合により、以前はEVARやTEVARに適さないと考えられていた横隔動脈瘤や胸腹部動脈瘤への適用が拡大しています。

画像診断の役割は大動脈内挿術の成功に不可欠となっています。高解像度の術前CT血管造影、3D血管マッピング、術中の透視またはコーンビームCTにより、正確なデバイスのサイズ決定、ランディングゾーンの特定、リアルタイムのグラフトナビゲーションが可能になりました。先進的なフュージョンイメージングプラットフォームは現在、術前スキャンを血管造影のライブビューにオーバーレイすることでダイナミックガイダンスを提供し、造影剤の使用量、放射線被曝、手術時間を大幅に削減しています。これらのツールは、エンドリークのリスクや手技合併症を最小限に抑えながら、術者が最適なシーリングとアライメントを達成するのに役立っています。

材料の革新はグラフトの耐久性と生体適合性をさらに向上させています。ポリエステル織布やヘパリン結合表面を持つePTFEなどのグラフト生地の改良により、血栓抵抗性が向上し、炎症反応が最小限に抑えられ、インプラントの寿命が延びています。長期的な性能は、特に若い患者や活動的な患者において、材料の耐疲労性、半径方向の強度、適合性と密接に関連しています。機器技術の進歩に伴い、再挿入率の低減と、移植内挿術治療の長期的な臨床的耐久性の向上に焦点が移りつつあります。

どのような臨床適応と地域市場が大動脈内移植片採用の成長を牽引しているか？

大動脈内皮移植の最も一般的な適応は腹部大動脈瘤（AAA）修復術であり、多くの高所得市場ではEVARが標準治療となっています。TEVARを用いた胸部大動脈瘤（TAA）修復術も、特に複雑な分岐グラフトを必要とする下行大動脈病変や大動脈弓伸展症例で採用されるようになってきています。その他の臨床適応としては、外傷性大動脈切断、慢性B型解離、多発性大動脈疾患におけるハイブリッド修復などがあり、血管の専門分野全体にわたって手技量とデバイスの利用が拡大しています。

高齢化が進み、心血管疾患の有病率が高く、病院のインフラ整備が進んでいる国々での需要は特に強いです。北米と西欧は成熟した市場であり、良好な償還政策、充実した検診プログラム、外科専門医のトレーニングによって支えられているため、手技の普及率は高いです。一方、アジア太平洋は、中国、インド、韓国、日本における認知度の向上、血管プログラムの拡大、インフラのアップグレードにより、成長が加速しています。ラテンアメリカや東欧でも、政府が資金を提供する心臓・血管治療拡大イニシアチブを通じて導入が増加しています。

特に65歳以上の男性の早期動脈瘤検診を重視する公衆衛生政策が、先進諸国での需要を強化しています。これと並行して、新興市場の民間ヘルスケア・ネットワークや専門病院は、価値の高い心臓血管手術を誘致するために血管内治療機能に投資しています。医療制度が低侵襲治療、短い入院期間、アウトカムに基づく償還を優先させる中、大動脈内移植片は動脈瘤修復や血管外傷への対応において優先される選択肢としての位置づけを強めています。

規制動向、競合情勢、市販後調査は市場情勢にどのような影響を与えているか？

規制当局は、手技の安全性と長期的な機器性能の両方を確保するために、大動脈内移植片の承認パスウェイとサーベイランス・プロトコルを改良しています。主要な市場において、規制の枠組みは現在、耐久性、解剖学的適合性、手技の再現性についての確固たる証拠を要求しています。機器登録、追跡画像診断の義務化、有害事象報告などの市販後調査プログラムは、製品のライフサイクル管理とメーカーの説明責任を形成しています。

メーカー各社は、グラフトデザイン、送達システムの人間工学、エンドリーク緩和戦略における革新によって差別化を図っています。競争上の位置づけは、展開の容易さ、解剖学的多様性、ハイブリッドや分岐型構成とのデバイス互換性によって推進されています。一部のプレーヤーは、製造リードタイムを短縮し、緊急時の使用準備を向上させるために、医師が変更可能な、あるいは既製の分岐型内挿術を提供しています。画像診断会社やトレーニング機関との戦略的パートナーシップは、ブランドロイヤリティと手技の標準化を強化しています。

アウトカムと費用対効果がより重視される中、いくつかのヘルスケアシステムでバリューベースの調達モデルが出現しています。病院や支払者は、大動脈内移植片を単価だけでなく、再介入率、長期耐久性、画像診断の負担を含む総治療費で評価するようになっています。ヘルスケアの提供が精密医療とリアルタイムの手技サポートに向かうにつれ、スマートフィードバック、画像互換性、適応展開を統合したデバイスは、競合情勢においてプレミアムを獲得すると思われます。

大動脈内移植片市場の成長を促進する要因とは？

大動脈内移植片市場は、低侵襲治療に対する臨床需要、技術進歩、医療システムの嗜好の合流によって、着実に拡大しています。大動脈瘤の負担の増加、血管診断の改善、開腹手術からEVARやTEVARへの継続的な移行が市場の中心的促進要因です。主な成長促進要因としては、血管外傷の発生率の上昇、人口動態の高齢化、複雑かつ緊急性の高い症例における血管内修復術の適応拡大などが挙げられます。

継続的な機器の技術革新、高度な画像診断との統合、医師のトレーニング強化により、先進国および新興国のヘルスケアシステムの双方で手技の導入が加速しています。ハイブリッド手術室、血管センター・オブ・エクセレンス、集学的治療モデルへの戦略的投資は、血管内皮移植をベースとしたインターベンションに対する施設の準備態勢を強化しています。市場の拡大は、低侵襲血管修復術の臨床的・経済的価値を認める規制当局の合理化された承認と的を絞った償還政策によってさらに支えられています。

今後、大動脈内移植片市場の軌跡は、デバイス・プラットフォームが解剖学的複雑性、長期耐久性、手技ごとのカスタマイズにいかに効果的に対処するかによって形成されるであろう。血管内治療が進化し続ける中、大動脈内移植片は21世紀の大動脈疾患管理の決定的な礎石となり得るだろうか。

セグメント

製品タイプ（腹部大動脈グラフト,胸部大動脈グラフト）;素材（金属製エンドグラフト,ポリマー製エンドグラフト）;エンドユース（病院,外来手術センター,その他のエンドユース）

調査対象企業の例（注目の41社）

• Abbott Laboratories
• Altura Medical Inc.
• Aptus Endosystems Inc.
• Artivion Inc.
• B. Braun Melsungen AG
• Bentley InnoMed GmbH
• Biomerics LLC
• Boston Scientific Corporation
• Braile Biomedica
• Cardiatis S.A.
• Cardinal Health Inc.
• Cook Medical Inc.
• Cordis Corporation
• CryoLife Inc.
• Edwards Lifesciences
• Endologix LLC
• Endospan Ltd.
• Getinge AB
• JOTEC GmbH
• Koninklijke Philips N.V.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Aortic Endografts Market to Reach US$3.6 Billion by 2030

The global market for Aortic Endografts estimated at US$2.9 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Abdominal Aortic Grafts, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Thoracic Aortic Grafts segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$796.1 Million While China is Forecast to Grow at 6.8% CAGR

The Aortic Endografts market in the U.S. is estimated at US$796.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$728.5 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Aortic Endografts Market - Key Trends & Drivers Summarized

Why Are Aortic Endografts Redefining the Standard of Care in Aneurysm Repair and Vascular Disease Management?

Aortic endografts-used in endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR)-have revolutionized the treatment of aortic aneurysms by enabling minimally invasive interventions that significantly reduce perioperative risk, hospital stay, and recovery time. These graft-stent hybrids are deployed inside the aorta to exclude aneurysmal sacs from blood flow, preventing rupture while preserving vascular continuity. Their use has become central in managing abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), especially in high-risk or elderly patients who are not ideal candidates for open surgical repair.

The transition from open surgery to EVAR and TEVAR is supported by strong clinical outcomes, including lower procedural mortality, reduced postoperative complications, and faster patient mobilization. Aortic endografts are increasingly being used in both elective and emergency settings, including ruptured aneurysms and traumatic aortic injuries, underscoring their growing relevance in acute vascular care. Their precision-engineered architecture-comprising self-expanding metallic stents and biocompatible graft fabrics-enables tailored solutions for complex anatomies and challenging vascular access pathways.

Beyond aneurysm exclusion, aortic endografts are gaining traction in hybrid and branched endovascular procedures for aortic dissections, penetrating atherosclerotic ulcers, and other pathologies involving the thoracic and abdominal aorta. These expanded indications, along with supportive clinical data and evolving surgical expertise, are driving greater adoption among vascular surgeons and interventional radiologists. As patient selection broadens and device versatility improves, aortic endografts are redefining therapeutic possibilities in vascular medicine.

How Are Device Design Innovations and Imaging Integration Enhancing Procedural Precision and Outcomes?

Advancements in device design are transforming aortic endografts into highly customizable, anatomy-conforming implants that accommodate wide variations in aortic diameter, tortuosity, and branch vessel proximity. Modular graft systems, low-profile delivery sheaths, and repositionable stent components are improving navigation through narrow or calcified iliac arteries, enabling safe deployment even in patients with hostile anatomies. The integration of suprarenal fixation, active sealing rings, and fenestrated or branched designs is extending applicability to juxtarenal and thoracoabdominal aneurysms previously considered unsuitable for EVAR or TEVAR.

The role of imaging has become integral to the success of aortic endograft placement. High-resolution preoperative CT angiography, 3D vascular mapping, and intraoperative fluoroscopy or cone-beam CT enable precise device sizing, landing zone identification, and real-time graft navigation. Advanced fusion imaging platforms now offer dynamic guidance by overlaying pre-op scans onto live angiographic views, significantly reducing contrast use, radiation exposure, and operative time. These tools are helping operators achieve optimal sealing and alignment, while minimizing endoleak risk and procedural complications.

Material innovation is further enhancing graft durability and biocompatibility. Improvements in graft fabrics, such as woven polyester and ePTFE with heparin-bonded surfaces, are improving thromboresistance, minimizing inflammatory response, and extending implant longevity. Long-term performance is being closely linked to material fatigue resistance, radial strength, and conformability, especially in younger or more active patients. As device technology advances, the focus is shifting toward reducing reintervention rates and improving long-term clinical durability of endograft therapy.

Which Clinical Indications and Regional Markets Are Driving Growth in Aortic Endograft Adoption?

The most common indication for aortic endograft use remains abdominal aortic aneurysm (AAA) repair, where EVAR has become the standard of care in many high-income markets. Thoracic aortic aneurysm (TAA) repair using TEVAR is also gaining adoption, especially for descending aorta involvement and aortic arch extension cases requiring complex branched grafts. Additional clinical indications include traumatic aortic transections, chronic type B dissections, and hybrid repairs in multilevel aortic disease-broadening procedural volumes and device utilization across vascular specialties.

Demand is particularly strong in countries with aging populations, high cardiovascular disease prevalence, and advanced hospital infrastructure. North America and Western Europe are mature markets with high procedural penetration, sustained by favorable reimbursement policies, robust screening programs, and specialist surgical training. Meanwhile, Asia-Pacific is witnessing accelerated growth due to rising awareness, expanding vascular programs, and infrastructure upgrades in China, India, South Korea, and Japan. Latin America and Eastern Europe are also increasing adoption through government-funded cardiac and vascular care expansion initiatives.

Public health policies that emphasize early aneurysm screening, especially among men aged 65 and older, are reinforcing demand in developed countries. In parallel, private healthcare networks and specialty hospitals in emerging markets are investing in endovascular capabilities to attract high-value cardiovascular procedures. As health systems prioritize minimally invasive care, short inpatient stays, and outcome-based reimbursement, aortic endografts are increasingly positioned as the preferred option in aneurysm repair and vascular trauma response.

How Are Regulatory Trends, Competitive Differentiation, and Post-Market Surveillance Influencing the Market Landscape?

Regulatory authorities are refining approval pathways and surveillance protocols for aortic endografts to ensure both procedural safety and long-term device performance. In major markets, regulatory frameworks now require robust evidence of durability, anatomical compatibility, and procedural reproducibility. Post-market surveillance programs-including device registries, mandatory follow-up imaging, and adverse event reporting-are shaping product lifecycle management and manufacturer accountability.

Manufacturers are differentiating through innovations in graft design, delivery system ergonomics, and endoleak mitigation strategies. Competitive positioning is being driven by ease of deployment, anatomical versatility, and device compatibility with hybrid and branched configurations. Some players are offering physician-modifiable or off-the-shelf branched endografts to reduce manufacturing lead times and improve emergency use readiness. Strategic partnerships with imaging companies and training institutions are enhancing brand loyalty and procedural standardization.

With greater focus on outcomes and cost-effectiveness, value-based procurement models are emerging in several healthcare systems. Hospitals and payers are evaluating aortic endografts not only by their unit cost but by total treatment cost, including reintervention rates, long-term durability, and imaging burden. As healthcare delivery moves toward precision medicine and real-time procedural support, devices that integrate smart feedback, imaging compatibility, and adaptive deployment will command a premium in the competitive landscape.

What Are the Factors Driving Growth in the Aortic Endografts Market?

The aortic endografts market is expanding steadily, driven by a confluence of clinical demand, technological advancement, and health system preferences for minimally invasive therapies. The growing burden of aortic aneurysms, improvements in vascular diagnostics, and continued migration from open surgery to EVAR and TEVAR procedures are core market drivers. Key growth enablers include the rising incidence of vascular trauma, aging demographics, and expanded indications for endovascular repair in complex and urgent cases.

Ongoing device innovation, integration with advanced imaging, and enhanced physician training are accelerating procedural adoption across both developed and emerging healthcare systems. Strategic investments in hybrid ORs, vascular centers of excellence, and multidisciplinary care models are reinforcing institutional readiness for endograft-based interventions. Market expansion is further supported by streamlined regulatory approvals and targeted reimbursement policies that recognize the clinical and economic value of minimally invasive vascular repair.

Looking ahead, the trajectory of the aortic endografts market will be shaped by how effectively device platforms address anatomical complexity, long-term durability, and procedure-specific customization. As endovascular care continues to evolve, could aortic endografts emerge as the definitive cornerstone of 21st-century aortic disease management?

SCOPE OF STUDY:

The report analyzes the Aortic Endografts market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Abdominal Aortic Grafts, Thoracic Aortic Grafts); Material (Metallic Endografts, Polymeric Endografts); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Abbott Laboratories
• Altura Medical Inc.
• Aptus Endosystems Inc.
• Artivion Inc.
• B. Braun Melsungen AG
• Bentley InnoMed GmbH
• Biomerics LLC
• Boston Scientific Corporation
• Braile Biomedica
• Cardiatis S.A.
• Cardinal Health Inc.
• Cook Medical Inc.
• Cordis Corporation
• CryoLife Inc.
• Edwards Lifesciences
• Endologix LLC
• Endospan Ltd.
• Getinge AB
• JOTEC GmbH
• Koninklijke Philips N.V.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Aortic Endografts - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Abdominal and Thoracic Aneurysms Throws the Spotlight on Aortic Endograft Therapies
  • Growth in Minimally Invasive Surgical Procedures Spurs Adoption of EVAR and TEVAR Solutions
  • OEM Advancements in Branched and Fenestrated Endografts Strengthen Business Case for Complex Aneurysm Repair
  • Increasing Surgical Preference for Endovascular Solutions Bodes Well for Shorter Recovery and Hospital Stay
  • Expansion of Geriatric and Comorbidity-Rich Patient Populations Drives Demand for Low-Risk Aneurysm Repair
  • Surge in Hybrid Operating Rooms and Imaging Infrastructure Supports High-Precision Endograft Placement
  • Growth in Peripheral Vascular Disease Management Expands Use of Ancillary Devices With Aortic Grafts
  • Public and Private Healthcare Investment in Cardiovascular Infrastructure Fuels Global Market Access
  • Adoption of Endograft-Based Reintervention Protocols Supports Market Expansion in Recurrent Aneurysm Management
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Aortic Endografts Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Aortic Endografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Aortic Endografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Aortic Endografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Abdominal Aortic Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Abdominal Aortic Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Abdominal Aortic Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Thoracic Aortic Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Thoracic Aortic Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Thoracic Aortic Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Metallic Endografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Metallic Endografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Metallic Endografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Polymeric Endografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Polymeric Endografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Polymeric Endografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: USA 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: Canada 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Japan 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: China 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Aortic Endografts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Aortic Endografts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Europe 15-Year Perspective for Aortic Endografts by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: France 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Germany 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Italy 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: UK 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Spain 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 119: Russia Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Russia Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Russia 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Europe Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Rest of Europe 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Endografts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 138: Asia-Pacific Historic Review for Aortic Endografts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Asia-Pacific 15-Year Perspective for Aortic Endografts by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 149: Australia Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Australia Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Australia 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 158: India Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: India Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: India 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 161: India Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: South Korea 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Aortic Endografts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Aortic Endografts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Latin America 15-Year Perspective for Aortic Endografts by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 197: Argentina Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Argentina Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Argentina 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 206: Brazil Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Brazil Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Brazil 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 215: Mexico Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Mexico Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Mexico 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Latin America Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Rest of Latin America 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 233: Middle East Recent Past, Current & Future Analysis for Aortic Endografts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 234: Middle East Historic Review for Aortic Endografts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Middle East 15-Year Perspective for Aortic Endografts by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 245: Iran Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Iran Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Iran 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 254: Israel Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Israel Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Israel 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Saudi Arabia Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Saudi Arabia 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 272: UAE Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: UAE Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: UAE 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Rest of Middle East Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Rest of Middle East 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Aortic Endografts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 290: Africa Recent Past, Current & Future Analysis for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Africa Historic Review for Aortic Endografts by Product Type - Abdominal Aortic Grafts and Thoracic Aortic Grafts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Africa 15-Year Perspective for Aortic Endografts by Product Type - Percentage Breakdown of Value Sales for Abdominal Aortic Grafts and Thoracic Aortic Grafts for the Years 2015, 2025 & 2030
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Aortic Endografts by Material - Metallic Endografts and Polymeric Endografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Aortic Endografts by Material - Percentage Breakdown of Value Sales for Metallic Endografts and Polymeric Endografts for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Aortic Endografts by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Aortic Endografts by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION